Streetbeat News

Regulatory

MNTS

Momentus has been granted continued listing on Nasdaq by a hearings panel, contingent on filing Form 10-Q by October 14. The company plans to file the form as soon as practicable.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 7:00 pm

AREB

CRKN

FDS

KAVL

SHCR

SRPT

SWBI

U.S. stocks traded mixed with the Nasdaq Composite moving lower. FactSet Research Systems posted better-than-expected earnings, leading to a 3% rise in its stock. American Rebel Holdings, Sharecare, and Sarepta Therapeutics saw significant gains due to various positive developments, while Kaival Brands Innovations, Crown Electrokinetics, and Smith & Wesson Brands experienced notable declines.

Portfolio Pulse from Avi Kapoor

June 21, 2024 | 6:58 pm

LLY

NVO

UNH

A House panel is considering a new plan for Medicare to cover Wegovy, a weight-loss drug, and cancer blood tests. This could impact companies like Novo Nordisk (NVO), the maker of Wegovy, and other healthcare providers.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 6:42 pm

NXL

Nexalin Technology, Inc. (NASDAQ:NXL) shares surged by 97.3% following the announcement of a new patent for its Deep Intracranial Frequency Stimulation (DIFS) device, aimed at treating Alzheimer's and dementia. The patent expands the company's intellectual property and highlights the potential of DIFS technology in the mental health market.

Portfolio Pulse from Vaishali Prayag

June 21, 2024 | 5:54 pm

CTLT

SRPT

TMO

Sarepta's expanded approval for Elevidys is expected to generate significant revenue, benefiting Catalent's growth. Despite this, Catalent's manufacturing capacity and the role of Thermo Fisher Scientific as a secondary manufacturer remain uncertain. Novo Holdings' acquisition of Catalent is unlikely to be influenced by this approval, but it provides some downside protection for investors.

Portfolio Pulse from Vandana Singh

June 21, 2024 | 5:52 pm

The FDA has approved the marketing of four menthol-flavored e-cigarette products from NJOY LLC, an affiliate of Altria Group Inc (NYSE:MO). This marks the first time non-tobacco flavored e-cigarette products have received FDA authorization. The decision aims to provide a less harmful alternative to traditional cigarettes for adult smokers, with stringent marketing restrictions to prevent youth access.

Portfolio Pulse from Shivani Kumaresan

June 21, 2024 | 5:42 pm

ITA

PPA

XAR

President Joe Biden has lifted restrictions on Ukraine's use of U.S.-provided munitions to fire back at Russia, as Russia continues to attack from within its borders. The Kremlin seeks comprehensive security talks with the White House, while the U.S. redirects air defense interceptor missiles to Ukraine. ETFs related to aerospace and defense showed mixed performance in response to these developments.

Portfolio Pulse from Michael Juliano

June 21, 2024 | 5:38 pm

BNB

TONUSD

UPHOLD

USDTUSD

Binance has integrated Tether (USDT) on The Open Network (TON), enhancing transaction speeds and lowering fees for users. This comes ahead of regulatory changes in the EEA, with MiCA imposing restrictions on unauthorized stablecoins. Uphold will delist USDT and five other stablecoins by July 1.

Portfolio Pulse from Murtuza Merchant

June 21, 2024 | 5:13 pm

SRPT

The FDA has expanded the approval of Sarepta Therapeutics Inc's (NASDAQ:SRPT) Elevidys to include individuals with Duchenne muscular dystrophy (DMD) who are at least four years old. This expansion is expected to lead to rapid uptake and substantial revenue growth for Sarepta. William Blair reiterates an Outperform rating with a fair value estimate of $210 per share. The approval is a significant milestone for Sarepta's DMD franchise and validates its gene therapy platform.

Portfolio Pulse from Vandana Singh

June 21, 2024 | 4:50 pm

AAPL

VGK

Apple announced that enhancements to iPhone mirroring, SharePlay screen sharing, and Apple Intelligence are unlikely to be rolled out to EU users this year.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 4:38 pm